Halonova Cream contains Halobetasol 0.05% w/w, a potent topical corticosteroid indicated for the treatment of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Halobetasol exerts anti-inflammatory, antipruritic, and vasoconstrictive effects by modulating the release of inflammatory mediators and suppressing immune responses in the skin. Halonova Cream is primarily used in conditions such as psoriasis, eczema, dermatitis, and lichen planus, where rapid symptom relief is desired. The formulation allows for effective penetration into the epidermis, providing targeted action with minimal systemic absorption when used as directed. It is recommended for short-term use due to the risk of potential side effects associated with potent corticosteroids, including skin atrophy, telangiectasia, and hypothalamic-pituitary-adrenal axis suppression if overused or applied over large body areas. Halonova Cream should be applied sparingly to the affected area once or twice daily, avoiding contact with eyes and mucous membranes. Patients should be advised to adhere strictly to prescribed duration and dosage to minimize adverse effects. Use during pregnancy and lactation should be under medical supervision. Discontinuation should be gradual to prevent rebound symptoms. Halonova Cream is contraindicated in viral, fungal, or bacterial skin infections unless appropriate antimicrobial therapy is concurrently administered.